Health Care Equipment & Services

Tarheel Investors’ $127 per‑share cash‑swap stake in Integer Holdings ties their upside to the Armstrong merger, giving investors a clear upside window amid proxy litigation and pending regulatory approval.

GoodRx insider Fengler Justin’s recent $3.50 buy shows confidence amid volatile trading – a subtle signal for investors to watch future rebounds.

Centene insider Carson Michael A sells 7,130 shares, yet keeps 115k+. His move signals strategic liquidity, not distress, while senior execs maintain long‑term stakes.

Investors learn Aethlon Medical’s new RSU grant ties senior execs to its North Immunology merger, boosting confidence in future growth while spotlighting insider activity and share volatility.

Insider buying spree: CIO Evans Tyler Matthew buys 17.8 M Nakamoto shares, boosting confidence amid volatile stock—what it means for investors.

AMN Healthcare insider trading shows steady growth, RSU‑driven gains, and cautious sales—insight for investors on potential dilution and long‑term value.

Inside Aethlon Medical: insider sales reveal potential bearish shift amid volatility and upcoming merger, offering key clues for investors.

Insider buys at QTREX Quantum: Parnes Tal’s 6,666‑share purchase signals confidence amid a volatile, high‑reward quantum‑med tech turn‑around.

CEO Atay Oguzhan’s Rule 10b5‑1 trades reveal a disciplined, long‑term buy‑low, sell‑high strategy that signals confidence in BillionToOne’s upside while mitigating insider‑trading risks.

Nanox Imaging CFO receives $50k RSU grant, signaling board confidence amid product and regulatory milestones, with modest dilution but strong investor buzz.